deltatrials
Unknown PHASE2 INTERVENTIONAL 2-arm NCT03671850

VT-EBV-N for Treatment of Severe in EBV Positive Extranodal NK/T Cell Lymphoma Patients

A Phase 2 Study to Evaluate the Efficacy and Safety of Postremission Therapy Using VT-EBV-N in EBV Positive Extranodal NK/T Cell Lymphoma Patients

Sponsor: ViGenCell Inc.

Conditions Extranodal NK/T-cell Lymphoma
Interventions Placebo VT-EBV-N
Updated 14 times since 2018 Last updated: Apr 28, 2022 Started: Apr 9, 2019 Primary completion: Dec 4, 2023 Completion: Jun 3, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Extranodal NK/T-cell Lymphoma and is currently ongoing. ViGenCell Inc. leads this study, which shows 14 recorded versions since 2019 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Oct 2018 – ~Dec 2018 · 2 months · monthly snapshot~Dec 2018 – ~Jan 2019 · 31 days · monthly snapshot~Jan 2019 – ~Feb 2019 · 31 days · monthly snapshot~Feb 2019 – ~Mar 2019 · 28 days · monthly snapshot~Mar 2019 – ~Apr 2019 · 31 days · monthly snapshot~Apr 2019 – ~May 2019 · 30 days · monthly snapshot~May 2019 – ~Aug 2019 · 3 months · monthly snapshot~Aug 2019 – ~Dec 2019 · 4 months · monthly snapshot~Dec 2019 – ~Jan 2021 · 13 months · monthly snapshot~Jan 2021 – ~May 2022 · 16 months · monthly snapshot~May 2022 – ~Jul 2024 · 26 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 12 months · monthly snapshot

Change History

14 versions recorded

  1. Sep 2025 — Present [monthly]

    Unknown PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Unknown PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE2

    Status: Recruiting → Unknown

  4. May 2022 — Jul 2024 [monthly]

    Recruiting PHASE2

  5. Jan 2021 — May 2022 [monthly]

    Recruiting PHASE2

▶ Show 9 earlier versions

  1. Dec 2019 — Jan 2021 [monthly]

    Recruiting PHASE2

  2. Aug 2019 — Dec 2019 [monthly]

    Recruiting PHASE2

  3. May 2019 — Aug 2019 [monthly]

    Recruiting PHASE2

  4. Apr 2019 — May 2019 [monthly]

    Recruiting PHASE2

    Status: Not Yet Recruiting → Recruiting

  5. Mar 2019 — Apr 2019 [monthly]

    Not Yet Recruiting PHASE2

  6. Feb 2019 — Mar 2019 [monthly]

    Not Yet Recruiting PHASE2

  7. Jan 2019 — Feb 2019 [monthly]

    Not Yet Recruiting PHASE2

  8. Dec 2018 — Jan 2019 [monthly]

    Not Yet Recruiting PHASE2

  9. Oct 2018 — Dec 2018 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • ViGenCell Inc.
Data source: ViGenCell Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations